Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Development of Miltefosine for the Leishmaniases

Author(s): J. D. Berman

Volume 6, Issue 2, 2006

Page: [145 - 151] Pages: 7

DOI: 10.2174/138955706775475993

Price: $65

Abstract

The leishmaniases consist of visceral and cutaneous syndromes present in > 30 endemic regions of the world. Miltefosine (hexadecylephosphocholine) is the first oral agent that is effective and tolerated for both visceral and cutaneous disease in several endemic regions, and represents a major advance in the treatment of these diseases.

Keywords: Miltefosine, visceral leishmaniasis, cutaneous leishmaniasis, efficacy, tolerance


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy